Health facilities in Mbarara City are struggling to keep up with surging demand for Lenacapavir, the revolutionary HIV prevention injection that only needs to be taken twice a year.The new injectable Pre-Exposure Prophylaxis (PrEP), popularly known as “
Medics in the Masaka sub-region have rolled out the use of injectable Lenacapavir amid calls for behavior change as a preventive measure in the fight against HIV.Addressing journalists in Masaka City during a health science café on June 19, Robert Bbosa, Infectious Diseases Institute Masa
Uganda is preparing for a major shift in HIV treatment as researchers and health officials work towards introducing long-acting injectable antiretroviral therapy (ART) that could replace daily HIV pills with injections taken once every two months.The new treatment, which combines cabotegra
The Uganda Peoples’ Defence Forces (UPDF), through its Health Services, has rolled out lenacapavir, a long-acting injectable Pre-Exposure Prophylaxis (PrEP) drug for HIV prevention which is administered once every six months, in a move aimed at strengthening its HIV response efforts.Spea
David Ssenfuka (L) and President MuseveniPresident Yoweri Kaguta Museveni has appealed to Members of Parliament to prioritise funding of critical areas in this year’s budget.Speaking to members of the ruling National Resistance Movement parliamentary caucus recently, President Mus
Global health is evolving rapidly, with breakthroughs turning into medicine.The latest advancement in viral research is Lenacapavir, an FDA-approved HIV injectable drug manufactured by American biopharmaceutical company Gilead Sciences.Renowned as a convenient, long-acting alternati
Uganda has received its first 19,200 doses of Lenacapavir, a twice-yearly injectable HIV prevention drug supported by the Global Fund and PEPFAR, targeting high-burden districts to curb new infections.Lenacapavir, a twice-yearly HIV prevention injection, is now accessible in Uganda.
Kampala — Uganda has approved Lenacapavir, a twice-yearly injectable HIV prevention medicine developed by Gilead Sciences, in a move health officials say could accelerate the country’s drive to sharply cut new infections and meet global targets to end AIDS as a public health threat by the end
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the country can sustainably finance emerging technologies in the face of waning donor support.Pharmacy and Medicines Regulatory Authority (PMRA) and National Aids Commission
According to the American Society of Plastic Surgeons, the Brazilian B*tt Lift, better known as a BBL, has become one of the defining cosmetic procedures of the last decade.Its rise has been fueled by social media trends and the infl
